Cardiology

  • Advances in the treatment of dyslipidemia
    Marc S. Sabatine, MD, MPH
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 181-186; DOI: https://doi.org/10.3949/ccjm.83gr.16001

    Current guidelines do not set specifi c targets for LDL-C, but evidence supports the concept that lower is better.

  • Interpreting SPRINT: How low should you go?
    George Thomas, MD, FACP, FASN, Joseph V. Nally, MD and Marc A. Pohl, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 187-195; DOI: https://doi.org/10.3949/ccjm.83a.15175

    In treating hypertension, lower systolic pressure is better than higher—but with caveats.

  • Blood pressure management in the wake of SPRINT
    Edward J. Filippone, MD, FACP and Andrew J. Foy, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 196-198; DOI: https://doi.org/10.3949/ccjm.83a.16015

    SPRINT should be interpreted in the context of prior trials and of its inclusion and exclusion criteria.

  • The intersection of obstructive lung disease and sleep apnea
    The intersection of obstructive lung disease and sleep apnea
    Sumita B. Khatri, MD, MS and Octavian C. Ioachimescu, MD, PhD
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 127-140; DOI: https://doi.org/10.3949/ccjm.83a.14104

    Many patients who have chronic obstructive pulmonary disease or asthma also have obstructive sleep apnea, and vice versa.

  • Prescribing exercise to help your patients lose weight
    John P. Higgins, MD, MBA, MPhil and Christopher L. Higgins, MCEP, BSHPE
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 141-150; DOI: https://doi.org/10.3949/ccjm.83a.14139

    It’s not enough to tell patients to exercise. The exercise you prescribe needs to be “SMART.”

  • Hope may not be the best component of an exercise regimen
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 89; DOI: https://doi.org/10.3949/ccjm.83b.02016

    Exercising to lose weight more often results in frustration than a trip to the store to buy smaller-sized clothes.

  • Can patients opt to turn off implantable cardioverter-defibrillators near the end of life?
    M. Motaz Baibars, MD, M. Chadi Alraies, MD, FACP, Amjad Kabach, MD and Marc Pritzker, MD, FACC
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 97-98; DOI: https://doi.org/10.3949/ccjm.83a.15007

    Yes, it is reasonable to consider deactivation near the end of life if the patient or family wishes.

  • The ethics of ICDs: History and future directions
    Martin L. Smith, STD and Eric Kodish, MD
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 99-100; DOI: https://doi.org/10.3949/ccjm.83a.15122

    There is no ethical requirement that treatment, once started, must continue against the patient’s wishes.

Pages